Sfoglia per Autore
Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells
2010-01-01 Germano G.; Frapolli R.; Simone M.; Tavecchio M.; Erba E.; Pesce S.; Pasqualini F.; Grosso F.; Sanfilippo R.; Casali P.G.; Gronchi A.; Virdis E.; Tarantino E.; Pilotti S.; Greco A.; Nebuloni M.; Galmarini C.M.; Tercero J.C.; Mantovani A.; D'Incalci M.; Allavena P.
New activities for the anti-tumor agent trabectedin: Taking two birds with one stone
2013-01-01 D'Incalci M.; Frapolli R.; Germano G.; Allavena P.
Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
2013-01-01 Germano G.; Frapolli R.; Belgiovine C.; Anselmo A.; Pesce S.; Liguori M.; Erba E.; Uboldi S.; Zucchetti M.; Pasqualini F.; Nebuloni M.; van Rooijen N.; Mortarini R.; Beltrame L.; Marchini S.; Fuso Nerini I.; Sanfilippo R.; Casali P.G.; Pilotti S.; Galmarini C.M.; Anichini A.; Mantovani A.; D'Incalci M.; Allavena P.
Trabectedin: A drug from the sea that strikes tumor-associated macrophages
2013-01-01 Allavena, Paola; Germano, Giovanni; Belgiovine, Cristina; D'Incalci, Maurizio; Mantovani, Alberto
Depletion of tumor-associated macrophages switches the epigenetic profile of pancreatic cancer infiltrating T cells and restores their anti-tumor phenotype
2018-01-01 Borgoni, Simone; Iannello, Andrea; Cutrupi, Santina; Allavena, Paola; D'Incalci, Maurizio; Novelli, Francesco; Cappello, Paola
Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells
2019-01-01 Amodio, V; Grmano, G; Barault, L; Lamba, S; Rospo, G; Magri, A; Maione, F; Crisafulli, G; Cancelliere, C; Lerda, G; Bartolini, A; Siravegna, G; Mussolin, B; Frappolli, R; Montone, M; Randon, G; de Braud, F; Angelozzi, NA; Marsoni, S; D'Incalci, M; Orlandi, A; Giraudo, E; Satore-Bianchi, A; Siena, S; Pietrantonio, F; Di Nicolantonio, F; Bardelli, A
Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma Group
2020-01-01 Grosso, Federica; D'Ambrosio, Lorenzo; Zucchetti, Massimo; Ibrahim, Toni; Tamberi, Stefano; Matteo, Cristina; Rulli, Eliana; Comandini, Danila; Palmerini, Emanuela; Baldi, Giacomo Giulio; DeCensi, Andrea; Bergaglio, Marina; Marra, Domenico; Marchesi, Emanuela; Siri, Giacomo; D'Incalci, Maurizio; Grignani, Giovanni
High-dose Vitamin C enhances cancer immunotherapy
2020-01-01 Magri A.; Germano G.; Lorenzato A.; Lamba S.; Chila R.; Montone M.; Amodio V.; Ceruti T.; Sassi F.; Arena S.; Abrignani S.; D'Incalci M.; Zucchetti M.; Di Nicolantonio F. *; Bardelli A.*; *co-last and corresponding authors
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line
2023-01-01 Colombo, N; Gadducci, A; Sehouli, J; Rulli, E; Mäenpää, J; Sessa, C; Montes, A; Ottevanger, N B; Berger, R; Vergote, I; D'Incalci, M; Churruca Galaz, C; Chekerov, R; Nyvang, G B; Riniker, S; Herbertson, R; Fossati, R; Barretina-Ginesta, M P; Deryal, M; Mirza, M R; Biagioli, E; Iglesias, M; Funari, G; Romeo, M; Tasca, G; Pardo, B; Tognon, G; Rubio-Pérez, M J; DeCensi, A; De Giorgi, U; Zola, P; Benedetti Panici, P; Aglietta, M; Arcangeli, V; Zamagni, C; Bologna, A; Westermann, A; Heinzelmann-Schwarz, V; Tsibulak, I; Wimberger, P; Poveda, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells | 2010 | Germano G.; Frapolli R.; Simone M.; Tavecchio M.; Erba E.; Pesce S.; Pasqualini F.; Grosso F.; Sanfilippo R.; Casali P.G.; Gronchi A.; Virdis E.; Tarantino E.; Pilotti S.; Greco A.; Nebuloni M.; Galmarini C.M.; Tercero J.C.; Mantovani A.; D'Incalci M.; Allavena P. | |
| New activities for the anti-tumor agent trabectedin: Taking two birds with one stone | 2013 | D'Incalci M.; Frapolli R.; Germano G.; Allavena P. | |
| Role of Macrophage Targeting in the Antitumor Activity of Trabectedin | 2013 | Germano G.; Frapolli R.; Belgiovine C.; Anselmo A.; Pesce S.; Liguori M.; Erba E.; Uboldi S.; Zucchetti M.; Pasqualini F.; Nebuloni M.; van Rooijen N.; Mortarini R.; Beltrame L.; Marchini S.; Fuso Nerini I.; Sanfilippo R.; Casali P.G.; Pilotti S.; Galmarini C.M.; Anichini A.; Mantovani A.; D'Incalci M.; Allavena P. | |
| Trabectedin: A drug from the sea that strikes tumor-associated macrophages | 2013 | Allavena, Paola; Germano, Giovanni; Belgiovine, Cristina; D'Incalci, Maurizio; Mantovani, Alberto | |
| Depletion of tumor-associated macrophages switches the epigenetic profile of pancreatic cancer infiltrating T cells and restores their anti-tumor phenotype | 2018 | Borgoni, Simone; Iannello, Andrea; Cutrupi, Santina; Allavena, Paola; D'Incalci, Maurizio; Novelli, Francesco; Cappello, Paola | |
| Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells | 2019 | Amodio, V; Grmano, G; Barault, L; Lamba, S; Rospo, G; Magri, A; Maione, F; Crisafulli, G; Cancelliere, C; Lerda, G; Bartolini, A; Siravegna, G; Mussolin, B; Frappolli, R; Montone, M; Randon, G; de Braud, F; Angelozzi, NA; Marsoni, S; D'Incalci, M; Orlandi, A; Giraudo, E; Satore-Bianchi, A; Siena, S; Pietrantonio, F; Di Nicolantonio, F; Bardelli, A | |
| Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma Group | 2020 | Grosso, Federica; D'Ambrosio, Lorenzo; Zucchetti, Massimo; Ibrahim, Toni; Tamberi, Stefano; Matteo, Cristina; Rulli, Eliana; Comandini, Danila; Palmerini, Emanuela; Baldi, Giacomo Giulio; DeCensi, Andrea; Bergaglio, Marina; Marra, Domenico; Marchesi, Emanuela; Siri, Giacomo; D'Incalci, Maurizio; Grignani, Giovanni | |
| High-dose Vitamin C enhances cancer immunotherapy | 2020 | Magri A.; Germano G.; Lorenzato A.; Lamba S.; Chila R.; Montone M.; Amodio V.; Ceruti T.; Sassi F.; Arena S.; Abrignani S.; D'Incalci M.; Zucchetti M.; Di Nicolantonio F. *; Bardelli A.*; *co-last and corresponding authors | |
| INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line | 2023 | Colombo, N; Gadducci, A; Sehouli, J; Rulli, E; Mäenpää, J; Sessa, C; Montes, A; Ottevanger, N B; Berger, R; Vergote, I; D'Incalci, M; Churruca Galaz, C; Chekerov, R; Nyvang, G B; Riniker, S; Herbertson, R; Fossati, R; Barretina-Ginesta, M P; Deryal, M; Mirza, M R; Biagioli, E; Iglesias, M; Funari, G; Romeo, M; Tasca, G; Pardo, B; Tognon, G; Rubio-Pérez, M J; DeCensi, A; De Giorgi, U; Zola, P; Benedetti Panici, P; Aglietta, M; Arcangeli, V; Zamagni, C; Bologna, A; Westermann, A; Heinzelmann-Schwarz, V; Tsibulak, I; Wimberger, P; Poveda, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile